Long non-coding RNA XIST regulates ovarian cancer progression via modulating miR-335/BCL2L2 axis
Open Access
- 5 June 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in World Journal of Surgical Oncology
- Vol. 19 (1), 1-12
- https://doi.org/10.1186/s12957-021-02274-7
Abstract
Background X inactivation-specific transcript (XIST) is the long non-coding RNA (lncRNA) related to cancer, which is involved in the development and progression of various types of tumor. However, up to now, the exact role and molecular mechanism of XIST in the progression of ovarian cancer are not clear. We studied the function of XIST in ovarian cancer cells and clinical tumor specimens. Methods RT-qPCR was performed to detect the expression levels of miR-335 and BCL2L2 in ovarian cancer cells and tissues. MTT and transwell assays were carried out to detect cell proliferation, migration, and invasion abilities. Western blot was performed to analyze the expression level of BCL2L2. The interaction between miR-335 and XIST/BCL2L2 was confirmed using a luciferase reporter assay. Results The inhibition of XIST can inhibit the proliferation invasion and migration of human ovarian cancer cells. In addition, the miR-335/BCL2L2 axis was involved in the functions of XIST in ovarian cancer cells. These results suggested that XIST could regulate tumor proliferation and invasion and migration via modulating miR-335/BCL2L2. Conclusion XIST might be a carcinogenic lncRNA in ovarian cancer by regulating miR-335, and it can serve as a therapeutic target in human ovarian cancer.Keywords
This publication has 43 references indexed in Scilit:
- MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathwayCarcinogenesis: Integrative Cancer Research, 2012
- MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1Oncogene, 2011
- Differential expression of microRNA-675, microRNA-139-3p and microRNA-335 in benign and malignant adrenocortical tumoursJournal of Clinical Pathology, 2011
- MicroRNA-34a: A Novel Tumor Suppressor in p53-mutant Glioma Cell Line U251Archives of Medical Research, 2010
- MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancerBiochemical and Biophysical Research Communications, 2009
- Evolution and Functions of Long Noncoding RNAsCell, 2009
- MicroRNA Expression and Identification of Putative miRNA Targets in Ovarian CancerPLOS ONE, 2008
- Endogenous human microRNAs that suppress breast cancer metastasisNature, 2008
- The Bcl-2 apoptotic switch in cancer development and therapyOncogene, 2007
- Oncomirs — microRNAs with a role in cancerNature Reviews Cancer, 2006